IL2 and cancer: The findings of differential expression of IL-2R during in vitro differentiation of human myeloid cells and increase in the number of colony-forming unit-granulocyte/macrophage (CFU-GM) progenitor cells after treatment of cancer patients with IL-2 are consistent with its positive effect on myelopoiesis.